Dawid S Zyla

Dr. Dawid S Zyla

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2021 in Science
Verified
Journal Article
Open access
KHKathryn M. Hastie
Kathryn M. Hastie
HLHaoyang Li
Haoyang Li
DBDaniel Bedinger
Daniel Bedinger
SSSharon L. Schendel
Sharon L. Schendel
SDS. Moses Dennison
S. Moses Dennison
ESErica Ollmann Saphire
Erica Ollmann Saphire
Community of antibodies against COVID-19: The severe acute respiratory syndrome coronavirus 2 spike protein is the basis of many vaccines and is a primary target of neutralizing antibodies after COVID-19 infection. The Coronavirus Immunotherapeutic Consortium (CoVIC), comprising 56 partners across the world, has analyzed a panel of 269 monoclonal antibodies (mAbs) and, on the basis of competition profiles, sorted 186 mAbs that target the receptor binding domain into seven communities. Hastie et al . went on to structurally analyze representative antibody binding and used pseudovirus neutralization assays to study the effect of spike mutations on antibody function, including the combinations of mutations found in certain variants of concern. These results are important to guide both treatment and prevention efforts. —VV

21 August 2020 in Science
Verified
Journal Article
Closed access
GWGregor L. Weiss
Gregor L. Weiss
JSJessica J. Stanisich
Jessica J. Stanisich
MSMaximilian M. Sauer
Maximilian M. Sauer
CLChia-Wei Lin
Chia-Wei Lin
JEJonathan Eras
Jonathan Eras
RGRudi Glockshuber
Rudi Glockshuber
How uromodulin helps flush out bacteria: Urinary tract infections (UTIs) are one of the most frequent bacterial infections in humans. The glycoprotein uromodulin is the most abundant urinary protein and can provide some protection from UTIs, but the precise mechanism has been unclear. Weiss et al. found that uromodulin forms stacked, fishbone-like filaments that act as a multivalent decoy for bacterial pathogens with adhesive pili that attach to the uromodulin glycans (see the Perspective by Kukulski). The resulting uromodulin-pathogen aggregates prevent bacterial adhesion to glycoproteins of the urinary epithelium and promote pathogen clearance as urine is excreted. This innate protection against UTIs is likely to be particularly important in infants and children. Science , this issue p. 1005 ; see also p. 917

17 June 2022 in Science Advances
Verified
Journal Article
Open access
HCHeather M. Callaway
Heather M. Callaway
DZDawid S Zyla
Dawid S Zyla
FLFlorence Larrous
Florence Larrous
GMGuilherme Dias de Melo
Guilherme Dias de Melo
KHKathryn M. Hastie
Kathryn M. Hastie
ESErica Ollmann Saphire
Erica Ollmann Saphire
Rabies infection is nearly 100% lethal if untreated and kills more than 50,000 people annually, many of them children. Existing rabies vaccines target the rabies virus glycoprotein (RABV-G) but generate short-lived immune responses, likely because the protein is heterogeneous under physiological conditions. Here, we report the 3.39 Å cryo–electron microscopy structure of trimeric, prefusion RABV-G complexed with RVA122, a potently neutralizing human antibody. RVA122 binds to a quaternary epitope at the top of RABV-G, bridging domains and stabilizing RABV-G protomers in a prefusion state. RABV-G trimerization involves side-to-side interactions between the central α helix and adjacent loops, rather than contacts between central helices, and interactions among the fusion loops at the glycoprotein base. These results provide a basis from which to develop improved rabies vaccines based on RABV-G stabilized in the prefusion conformation.

1 December 2017 in Structure
Verified
Journal Article
Open access
MHManuela K. Hospenthal
Manuela K. Hospenthal
DZDawid S Zyla
Dawid S Zyla
TCTiago R.D. Costa
Tiago R.D. Costa
ARAdam Redzej
Adam Redzej
CGChristoph Giese
Christoph Giese
GWGabriel Waksman
Gabriel Waksman
Adhesive chaperone-usher pili are long, supramolecular protein fibers displayed on the surface of many bacterial pathogens. The type 1 and P pili of uropathogenic Escherichia coli (UPEC) play important roles during urinary tract colonization, mediating attachment to the bladder and kidney, respectively. The biomechanical properties of the helical pilus rods allow them to reversibly uncoil in response to flow-induced forces, allowing UPEC to retain a foothold in the unique and hostile environment of the urinary tract. Here we provide the 4.2-Å resolution cryo-EM structure of the type 1 pilus rod, which together with the previous P pilus rod structure rationalizes the remarkable "spring-like" properties of chaperone-usher pili. The cryo-EM structure of the type 1 pilus rod differs in its helical parameters from the structure determined previously by a hybrid approach. We provide evidence that these structural differences originate from different quaternary structures of pili assembled in vivo and in vitro.

20 August 2020 in eLife
Verified
Journal Article
Open access
JSJessica J Stanisich
Jessica J Stanisich
DZDawid S Zyla
Dawid S Zyla
PAPavel Afanasyev
Pavel Afanasyev
JXJingwei Xu
Jingwei Xu
AKAnne Kipp
Anne Kipp
RGRudi Glockshuber
Rudi Glockshuber
The glycoprotein uromodulin (UMOD) is the most abundant protein in human urine and forms filamentous homopolymers that encapsulate and aggregate uropathogens, promoting pathogen clearance by urine excretion. Despite its critical role in the innate immune response against urinary tract infections, the structural basis and mechanism of UMOD polymerization remained unknown. Here, we present the cryo-EM structure of the UMOD filament core at 3.5 Å resolution, comprised of the bipartite zona pellucida (ZP) module in a helical arrangement with a rise of ~65 Å and a twist of ~180°. The immunoglobulin-like ZPN and ZPC subdomains of each monomer are separated by a long linker that interacts with the preceding ZPC and following ZPN subdomains by β-sheet complementation. The unique filament architecture suggests an assembly mechanism in which subunit incorporation could be synchronized with proteolytic cleavage of the C-terminal pro-peptide that anchors assembly-incompetent UMOD precursors to the membrane.

28 June 2024 in Science
Verified
Journal Article
Closed access
DZDawid S Zyla
Dawid S Zyla
RMRoberta Della Marca
Roberta Della Marca
GNGele Niemeyer
Gele Niemeyer
GZGillian Zipursky
Gillian Zipursky
KSKyle Stearns
Kyle Stearns
ESErica Ollmann Saphire
Erica Ollmann Saphire
Measles virus (MeV) presents a public health threat that is escalating as vaccine coverage in the general population declines and as populations of immunocompromised individuals, who cannot be vaccinated, increase. There are no approved therapeutics for MeV. Neutralizing antibodies targeting viral fusion are one potential therapeutic approach but have not yet been structurally characterized or advanced to clinical use. We present cryo–electron microscopy (cryo-EM) structures of prefusion F alone [2.1-angstrom (Å) resolution], F complexed with a fusion-inhibitory peptide (2.3-Å resolution), F complexed with the neutralizing and protective monoclonal antibody (mAb) 77 (2.6-Å resolution), and an additional structure of postfusion F (2.7-Å resolution). In vitro assays and examination of additional EM classes show that mAb 77 binds prefusion F, arrests F in an intermediate state, and prevents transition to the postfusion conformation. These structures shed light on antibody-mediated neutralization that involves arrest of fusion proteins in an intermediate state.